NCT03441815View on ClinicalTrials.gov

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 14, 2015

Primary Completion Date

July 7, 2015

Study Completion Date

July 7, 2015

Conditions

Asthma

Interventions

DRUG

XC8

DRUG

Placebo

Trial Locations (1)

119435

SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow

All Listed Sponsors

lead

PHARMENTERPRISES LLC

INDUSTRY

NCT03441815 - XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter